Transient elastography for predicting clinical outcomes in patients with chronic liver disease

Journal of Viral Hepatitis

Volumn 19, Issue 2, 2012, Pages

  Klibansky, D A ^a   Mehta, S H ^b   Curry, M ^c   Nasser, I ^a   Challies, T ^a   Afdhal, N H ^c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Beth Israel Deaconess Medical Center   (Israel)

Author keywords

area under the receiver operating characteristic curve; fibroscan; fibrosis; stiffness

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; ARTICLE; ASCITES; BLEEDING; CHILD SCORE; CHRONIC LIVER DISEASE; DEATH; DECOMPENSATED LIVER CIRRHOSIS; DISEASE SEVERITY; ELASTOGRAPHY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL; MODEL FOR END STAGE LIVER DISEASE; OUTCOME ASSESSMENT; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TRANSIENT ELASTOGRAPHY; VARICOSIS;

ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 84855826570     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01493.x     Document Type: Article

References (31)

1. Thampanitchawong P, Piratvisuth T,. Liver biopsy: complications and risk factors. World J Gastroenterol 1999; 5: 301-304.
2. Froehlich F, Lamy O, Fried M, et al. Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland. Dig Dis Sci 1993; 38: 1480-1484. (Pubitemid 23266629)
3. Abdi W, Millan JC, Mezey E,. Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979; 139: 667-669. (Pubitemid 10097795)
4. Maharaj B, Maharaj RJ, Leary WP, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523-525. (Pubitemid 16138427)
5. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-2618.
6. Hammel P, Couvelard A, O'Toole D, et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 2001; 344: 418-423. (Pubitemid 32128674)
7. Dufour JF, DeLellis R, Kaplan MM,. Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med 1997; 127: 981-985. (Pubitemid 27516609)
8. Schiff ER, Heathcote J, Dienstag JL, et al. Improvements in liver histology and cirrhosis with extended lamivudine therapy. Hepatology 2000; 32: 296.
9. Dufour JF, DeLellis R, Kaplan MM,. Regression of hepatic fibrosis in hepatitis C with long-term interferon therapy. Dig Dis Sci 1998; 43: 2573-2576. (Pubitemid 29034906)
10. Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-1075. (Pubitemid 32322537)
11. Poynard T, Imbert-Bismut F, Munteanu M, et al. Overview of the diagnostic value of biochemical markers of liver fibrosis [FibroTest, HCV FibroSure] and necrosis [ActiTest] in patients with chronic hepatitis C. Comp Hepatol 2004; 3: 8.
12. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54. (Pubitemid 40066382)
13. Verveer C, de Knegt RJ,. Noninvasive measurement of liver fibrosis: application of the FibroScan in hepatology. Scand J Gastroenterol Suppl 2006; 243: 85-88. (Pubitemid 43941071)
14. Talwalkar JA, Kurtz DM, Schoenleber SJ, et al. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2007; 5: 1214-1220. (Pubitemid 47488974)
15. Huwart L, Peeters F, Sinkus R, et al. Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed 2006; 19: 173-179.
16. Yin M, Talwalkar JA, Glaser KJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007; 5: 1207-1213.
17. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-1713. (Pubitemid 38091720)
18. Kettaneh A, Marcellin P, Douvin C, et al. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol 2007; 46: 628-634. (Pubitemid 46420381)
19. Castera L, Forns X, Alberti A,. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48: 835-847.
20. Fraquelli M, Rigamonti C, Casazza D, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56: 968-973. (Pubitemid 46999083)
21. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-350. (Pubitemid 40439195)
22. Vizzutti F, Arena U, Romanelli RG, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45: 1290-1297. (Pubitemid 46775793)
23. Carrion JA, Navasa M, Bosch J, et al. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006; 12: 1791-1798. (Pubitemid 44911805)
24. Vizzutti F, Arena U, Marra F, et al. Elastography for the non-invasive assessment of liver disease: limitations and future developments. Gut 2009; 58: 157-160.
25. Vergniol J, Foucher J, Castéra L, et al. Changes of non-invasive markers and FibroScan values during HCV treatment. J Viral Hepat 2009; 16: 132-140.
26. Bureau C, Metivier S, Peron JM, et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther 2008; 27 (12): 1261-1268. (Pubitemid 351697282)
27. Lemoine M, Katsahian S, Ziol M, et al. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment Pharmacol Ther 2008; 28: 1102-1110.
28. Kazemi F, Kettaneh G, N'kontchou G., et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006; 45: 230-235.
29. Mayo MJ, Parkes J, Adams-Huet B, et al. Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay. Hepatology 2008; 48: 1549-1557.
30. Huwart L, Sempoux C, Salameh N, et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 2007; 245: 458-466. (Pubitemid 47612527)
31. Huwart L, Sempoux C, Vicaut E, et al. Magnetic resonance elastography for the non-invasive staging of liver fibrosis. Gastroenterology 2008; 135: 32-40. (Pubitemid 351899024)